GLOBAL BIOSURGERY MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

GLOBAL BIOSURGERY MARKET 2019-2027

Market By Product, Application, Source Type And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

According to Triton, the global biosurgery market is expected to display a positive market trend over the forecast period of 2019-2027, exhibiting a CAGR of 8.52%. The market was assessed to be worth $9424.01 million in the year 2018 and is predicted to generate a revenue of approximately $19673.44 million by the year 2027.

Biosurgery in modern medicine means surgical procedures that comprise an array of natural or manmade equipment. Biomaterials consist of glues that are biologically compatible with lubricants that help joint movement and support on which living tissue is grown or shaped and seal surgical incisions. It also includes biocompatible materials such as artificial pacemakers and hip replacements and also bio-therapeutic techniques such as cellular and gene therapies. This sense is well-known in medical literature but does not have a reach to the general public, except a part of the companies that are active in the field.

We provide additional customization based on your specific requirements. Request For Customization 

The biosurgery market is anticipated to rise at a significant pace, owing to the growing sport & spine-related injuries, growth in surgeries because of the growing obese population, due to lifestyle disorders, increasing per capita healthcare expenditure, large investments, rising R&D expenditure, belligerent moves adopted by top-notch companies such as launching new product in the market and others. Additionally, the availability of multi-functional products would provide a lucrative opportunity to the market. For example, apart from fibrins used as sealants in surgery, they are also utilized as hemostatic agents that avert unnecessary loss of blood during orthopedic surgeries and cardiothoracic. However, the stern regulatory environment for product approval, high cost associated with surgeries and the rising popularity of minimally invasive surgeries are factors that would adversely affect market growth.

Biosurgery products increase the speed, improve the consistency and enhance the efficiency of surgeons with the use of various biomaterials that help in reducing intra-operative and post-operative complications. The report from Triton includes the market definition, key insights, trends in biosurgery technology, regulatory framework, key vendor outlook, key buying outlook and the key patent outlook for the varied regions. 

The market drivers like the aging population, surge in the surgical treatments for musculoskeletal disorders and the increasing trauma-related wounds have been studied in detail. The market restraints like stringent regulatory approval, increasing cost of surgeries, rising usage of minimally invasive surgeries and lack of awareness are the factors affecting the market growth drastically.

The development policy for reimbursement & compensation, increase in research & investment in bioengineering and the increasing healthcare spending are the key opportunities for market growth over the projected period. However, major challenges such as amplified scrutiny of stem cell-derived products, complications related to immune response, lack of significant differentiation in the range of products, product side-effects and FDA inquiry are impeding the growth of the market globally.

The geographies covered in the global biosurgery market are:

•    North America: United States and Canada

•    Europe: United Kingdom, Germany, France and Rest of Europe

•    Asia-Pacific: China, Japan, India, Australia and Rest of Asia-Pacific

•    Latin America: Brazil, Mexico and Rest of Latin America

•    The Middle East and Africa: United Arab Emirates, Saudi Arabia, Turkey, South Africa and Rest of the Middle East and Africa


The biosurgery market is segmented into:

•    By products:

O    Bonus-graft substitutes

•    Synthetic graft extender

•    Demineralized bone matrix

•    Bone morphogenetic proteins

•    Cell-based matrices

O    Hemostatic agents

O    Soft tissue management

•    Synthetic mesh/patch

•    Natural mesh/patch

O    Surgical sealing agents

•    Natural surgical agents

•    Synthetic surgical agents

O    Anti-adhesive agents

•    By application:

O    Neuro and spine surgery

O    Cardio and thoracic surgery

O    General surgery

O    Orthopedic surgery

•    By source type: 

O    Natural

O    Synthetic

The major key players engaged in the biosurgery market are Wright Medical Group N.V., Stryker Corporation, Sanofi, Ypsomed Holding AG, B. Braun Melsungen AG, Olympus Corporation, Smith & Nephew Plc, Medtronic Plc, Zimmer Biomet Holdings, Inc., Baxter International, Inc., RTI Surgical, Ethicon, Inc. and Johnson & Johnson.

The strategic analysis for each of these companies is covered in detail in the biosurgery market. The company market share helps to dive into the information about the key market players in this industry and their hold on the market.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    BIOSURGERY MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. TRENDS IN BIOSURGERY TECHNOLOGY

2.3. REGULATORY FRAMEWORK

2.4. KEY VENDORS OUTLOOK

2.5. KEY INSIGHTS

2.6. KEY BUYING OUTLOOK

2.7. KEY PATENT OUTLOOK

2.7.1.   EUROPE

2.7.2.   THE UNITED STATES

2.7.3.   ASIA-PACIFIC

2.7.3.1.      JAPAN PATENT ANALYSIS

2.7.3.2.      CHINA PATENT ANALYSIS

2.7.3.3.      KOREA PATENT ANALYSIS

2.8. MARKET DRIVERS

2.8.1.   AGING POPULATION

2.8.2.   SURGE IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS

2.8.3.   RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION

2.8.4.   SURGE IN THE OVERWEIGHT POPULATION

2.8.5.   INCREASING TRAUMA-RELATED WOUNDS

2.9. MARKET RESTRAINTS

2.9.1.   STRINGENT REGULATORY APPROVAL

2.9.2.   INCREASE IN THE COST OF SURGERIES

2.9.3.   INCREASING USAGE OF MINIMALLY INVASIVE SURGERIES

2.9.4.   LACK OF AWARENESS

2.10.  MARKET OPPORTUNITIES

2.10.1.  DEVELOPMENT OF POLICY FOR REIMBURSEMENT AND COMPENSATION

2.10.2.   INCREASE IN RESEARCH AND INVESTMENT IN BIOENGINEERING

2.10.3.   INCREASE IN HEALTHCARE SPENDING

2.11.  MARKET CHALLENGES

2.11.1.  AMPLIFIED SCRUTINY OF STEM CELL-DERIVED PRODUCTS

2.11.2.  COMPLICATION RELATED TO IMMUNE RESPONSE

2.11.3.   LACK OF SIGNIFICANT DIFFERENTIATION IN THE RANGE OF PRODUCTS

2.11.4.   PRODUCT SIDE-EFFECTS AND FDA INQUIRY

3.    BIOSURGERY MARKET OUTLOOK - BY PRODUCTS

3.1. BONE GRAFT SUBSTITUTES

3.1.1.   SYNTHETIC GRAFT EXTENDER

3.1.2.   DEMINERALIZED BONE MATRIX

3.1.3.   BONE MORPHOGENETIC PROTEINS

3.1.4.   CELL-BASED MATRICES

3.2. HEMOSTATIC AGENTS

3.3. SOFT TISSUE MANAGEMENT

3.3.1.   SYNTHETIC MESH/PATCH

3.3.2.   NATURAL MESH/PATCH

3.4. SURGICAL SEALING AGENTS

3.4.1.   NATURAL SURGICAL SEALING AGENTS

3.4.2.   SYNTHETIC SURGICAL SEALING AGENTS

3.5. ANTI-ADHESIVE AGENTS

4.    BIOSURGERY MARKET OUTLOOK - BY APPLICATION

4.1. NEURO AND SPINE SURGERY

4.2. CARDIO AND THORACIC SURGERY

4.3. GENERAL SURGERY

4.4. ORTHOPEDIC SURGERY

5.    BIOSURGERY MARKET OUTLOOK - BY SOURCE TYPE

5.1. NATURAL

5.2. SYNTHETIC

6.    BIOSURGERY MARKET - REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1.   MARKET BY PRODUCTS

6.1.2.   MARKET BY APPLICATION

6.1.3.   MARKET BY SOURCE TYPE

6.1.4.   COUNTRY ANALYSIS

6.1.4.1.      THE UNITED STATES

6.1.4.2.      CANADA

6.2. EUROPE

6.2.1.   MARKET BY PRODUCTS

6.2.2.   MARKET BY APPLICATION

6.2.3.   MARKET BY SOURCE TYPE

6.2.4.   COUNTRY ANALYSIS

6.2.4.1.      GERMANY

6.2.4.2.      THE UNITED KINGDOM

6.2.4.3.      FRANCE

6.2.4.4.      REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1.   MARKET BY PRODUCTS

6.3.2.   MARKET BY APPLICATION

6.3.3.   MARKET BY SOURCE TYPE

6.3.4.   COUNTRY ANALYSIS

6.3.4.1.      CHINA

6.3.4.2.      JAPAN

6.3.4.3.      INDIA

6.3.4.4.      AUSTRALIA

6.3.4.5.      REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1.   MARKET BY PRODUCTS

6.4.2.   MARKET BY APPLICATION

6.4.3.   MARKET BY SOURCE TYPE

6.4.4.   COUNTRY ANALYSIS

6.4.4.1.      BRAZIL

6.4.4.2.      MEXICO

6.4.4.3.      REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1.   MARKET BY PRODUCTS

6.5.2.   MARKET BY APPLICATION

6.5.3.   MARKET BY SOURCE TYPE

6.5.4.   COUNTRY ANALYSIS

6.5.4.1.      SAUDI ARABIA

6.5.4.2.      TURKEY

6.5.4.3.      THE UNITED ARAB EMIRATES

6.5.4.4.      SOUTH AFRICA

6.5.4.5.      REST OF MIDDLE EAST AND AFRICA

7.    COMPETITIVE LANDSCAPE

7.1. B. BRAUN MELSUNGEN AG

7.2. JOHNSON & JOHNSON

7.3. BAXTER INTERNATIONAL, INC.

7.4. ETHICON, INC.

7.5. MEDTRONIC PLC

7.6. SANOFI

7.7. OLYMPUS CORPORATION

7.8. RTI SURGICAL

7.9. SMITH & NEPHEW PLC

7.10. STRYKER CORPORATION

7.11.  ZIMMER BIOMET HOLDINGS, INC.

7.12.  WRIGHT MEDICAL GROUP N.V.

7.13.  YPSOMED HOLDING AG

8.    METHODOLOGY AND SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1        GLOBAL BIOSURGERY MARKET BY REGION 2019-2027 (IN $ MILLION)

TABLE 2        MEDICAL DEVICE CLASSIFICATION

TABLE 3        TYPES OF PMA SUPPLEMENTS

TABLE 4        MEDICAL DEVICES BY CLASS

TABLE 5        RULES AND REGULATIONS IN JAPAN

TABLE 6        REGISTRATION/APPROVAL OF PATENTS GLOBALLY 2010-2016 (%)

TABLE 7        GLOBAL BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)

TABLE 8        DIFFERENT TYPES OF BONE GRAFT SUBSTITUTES

TABLE 9        GLOBAL BIOSURGERY MARKET IN BONE GRAFT SUBSTITUTES BY TYPES 2019-2027 (IN $ MILLION)

TABLE 10      KEY OSTEOBIOLOGIC PRODUCTS AVAILABLE IN THE MARKET

TABLE 11      KEY SOFT TISSUE MANAGEMENT PRODUCTS AVAILABLE IN THE MARKET

TABLE 12      GLOBAL BIOSURGERY MARKET IN SOFT TISSUE MANAGEMENT BY TYPES 2019-2027 (IN $ MILLION)

TABLE 13      KEY SURGICAL SEALING AGENTS AVAILABLE IN THE MARKET

TABLE 14      GLOBAL BIOSURGERY MARKET IN SURGICAL SEALING AGENTS BY TYPES 2019-2027 (IN $ MILLION)

TABLE 15      GLOBAL BIOSURGERY MARKET BY APPLICATIONS 2019-2027 (IN $ MILLION)

TABLE 16      TYPES OF CARDIOVASCULAR DISEASES

TABLE 17      STAGES OF GRAFT HEALING AND THEIR CHARACTERISTICS

TABLE 18      GLOBAL BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)

TABLE 19      NORTH AMERICA BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)

TABLE 20      NORTH AMERICA BIOSURGERY MARKET BY APPLICATION 2019-2027 (IN $ MILLION)

TABLE 21      NORTH AMERICA BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)

TABLE 22      NORTH AMERICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

TABLE 23      EUROPE BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)

TABLE 24      EUROPE BIOSURGERY MARKET BY APPLICATION 2019-2027 (IN $ MILLION)

TABLE 25      EUROPE BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)

TABLE 26      EUROPE BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

TABLE 27      ASIA-PACIFIC BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)

TABLE 28      ASIA-PACIFIC BIOSURGERY MARKET BY APPLICATION 2019-2027 (IN $ MILLION)

TABLE 29      ASIA-PACIFIC BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)

TABLE 30      ASIA-PACIFIC BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

TABLE 31      LATIN AMERICA BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)

TABLE 32      LATIN AMERICA BIOSURGERY MARKET BY APPLICATION 2019-2027 (IN $ MILLION)

TABLE 33      LATIN AMERICA BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)

TABLE 34      LATIN AMERICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

TABLE 35      MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY PRODUCTS 2019-2027 (IN $ MILLION)

TABLE 36      MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY APPLICATION 2019-2027 (IN $ MILLION)

TABLE 37      MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY SOURCE TYPE 2019-2027 (IN $ MILLION)

TABLE 38      MIDDLE EAST AND AFRICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)    

List of Figures

FIGURE 1      GLOBAL BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 2      KEY STRATEGIES IN BIOSURGERY MARKET

FIGURE 3      EUROPE PATENT ANALYSIS BY PRODUCT 2010-2016 (%)

FIGURE 4      EUROPE PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016

FIGURE 5      U.S. PATENT ANALYSIS ON THE BASIS OF PRODUCT 2010-2016

FIGURE 6      U.S. PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016 (%)

FIGURE 7      JAPAN PATENT ANALYSIS BY PRODUCT 2010-2016

FIGURE 8      JAPAN PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016

FIGURE 9      CHINA PATENT ANALYSIS BY PRODUCT 2010-2016

FIGURE 10   CHINA PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016

FIGURE 11   KOREA PATENT ANALYSIS BY PRODUCT 2010-2016

FIGURE 12   KOREA PATENT ANALYSIS BY MARKET PARTICIPANT 2010-2016

FIGURE 13   LIFE EXPECTANCY OF GERIATRIC POPULATION GLOBALLY 2010-2050

FIGURE 14   PERCENTAGE DISTRIBUTION OF POPULATION AGED ABOVE 65, 2015 & 2050

FIGURE 15   PER CAPITA HEALTH EXPENDITURES FOR TOP COUNTRIES (%)

FIGURE 16   DIFFERENT TYPES OF NATURAL BIOSURGICAL SEALANTS

FIGURE 17   GLOBAL BIOSURGERY MARKET IN BONE GRAFT SUBSTITUTES 2019-2027 (IN $ MILLION)

FIGURE 18   GLOBAL BIOSURGERY MARKET IN HEMOSTATIC AGENTS 2019-2027 (IN $ MILLION)

FIGURE 19   GLOBAL BIOSURGERY MARKET IN SOFT TISSUE MANAGEMENT 2019-2027 (IN $ MILLION)

FIGURE 20   GLOBAL BIOSURGERY MARKET IN SURGICAL SEALING AGENTS 2019-2027 (IN $ MILLION)

FIGURE 21   GLOBAL BIOSURGERY MARKET IN ANTI-ADHESIVE AGENTS 2019-2027 (IN $ MILLION)

FIGURE 22   GLOBAL BIOSURGERY MARKET IN NEURO AND SPINE SURGERY 2019-2027 (IN $ MILLION)

FIGURE 23   GLOBAL BIOSURGERY MARKET IN CARDIO AND THORACIC SURGERY 2019-2027 (IN $ MILLION)

FIGURE 24   GLOBAL BIOSURGERY MARKET IN GENERAL SURGERY 2019-2027 (IN $ MILLION)

FIGURE 25   GLOBAL BIOSURGERY MARKET IN ORTHOPEDIC SURGERY 2019-2027 (IN $ MILLION)

FIGURE 26   GLOBAL BIOSURGERY MARKET IN NATURAL 2019-2027 (IN $ MILLION)

FIGURE 27   GLOBAL BIOSURGERY MARKET IN SYNTHETIC 2019-2027 (IN $ MILLION)

FIGURE 28   BIOSURGERY RESEARCH PROJECTS PATENT BY DIFFERENT ORGANIZATIONS 2016 (%)

FIGURE 29   NORTH AMERICA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 30   THE UNITED STATES BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 31   DIABETES PREVALENCE AMONG DIFFERENT AMERICAN ETHNICITIES (%)

FIGURE 32   CANADA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 33   EUROPE BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 34   RATE OF CHRONIC DISORDERS IN EUROPE 2016 (%)

FIGURE 35   GERMANY BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 36   THE UNITED KINGDOM BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 37   FRANCE BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 38   REST OF EUROPE BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 39   ASIA-PACIFIC BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 40   CHINA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 41   RATE OF GERIATRIC POPULATION STATISTICS, BY AGE IN JAPAN (%)

FIGURE 42   JAPAN BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 43   INDIA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 44   AUSTRALIA BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 45   REST OF ASIA-PACIFIC BIOSURGERY MARKET 2019-2027 (IN $ MILLION)

FIGURE 46   BRAZIL BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

FIGURE 47   MEXICO BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

FIGURE 48   REST OF LATIN AMERICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

FIGURE 49   SAUDI ARABIA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

FIGURE 50   TURKEY BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

FIGURE 51   THE UNITED ARAB EMIRATES BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

FIGURE 52   SOUTH AFRICA BIOSURGERY MARKET BY COUNTRY 2019-2027 (IN $ MILLION)

FIGURE 53   REST OF MIDDLE EAST AND AFRICA DENTAL DIAGNOSTICS AND SURGICAL EQUIPMENT MARKET 2019-2027 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;